nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—CYP1A2—Carmustine—malignant glioma	0.285	1	CbGbCtD
Rizatriptan—HTR1D—meninx—malignant glioma	0.0685	0.196	CbGeAlD
Rizatriptan—HTR1B—dura mater—malignant glioma	0.0651	0.187	CbGeAlD
Rizatriptan—HTR1D—dura mater—malignant glioma	0.0631	0.181	CbGeAlD
Rizatriptan—Melatonin—ASMT—malignant glioma	0.0173	1	CrCbGaD
Rizatriptan—HTR1B—telencephalic ventricle—malignant glioma	0.0162	0.0465	CbGeAlD
Rizatriptan—HTR1D—telencephalic ventricle—malignant glioma	0.0157	0.045	CbGeAlD
Rizatriptan—HTR1A—telencephalic ventricle—malignant glioma	0.0131	0.0375	CbGeAlD
Rizatriptan—Vasospasm—Carmustine—malignant glioma	0.0106	0.0442	CcSEcCtD
Rizatriptan—HTR1F—telencephalon—malignant glioma	0.00951	0.0273	CbGeAlD
Rizatriptan—Hyperacusis—Temozolomide—malignant glioma	0.00937	0.0392	CcSEcCtD
Rizatriptan—HTR1B—blood vessel—malignant glioma	0.00803	0.023	CbGeAlD
Rizatriptan—HTR1D—blood vessel—malignant glioma	0.00778	0.0223	CbGeAlD
Rizatriptan—HTR1F—central nervous system—malignant glioma	0.00541	0.0155	CbGeAlD
Rizatriptan—Parosmia—Temozolomide—malignant glioma	0.00538	0.0225	CcSEcCtD
Rizatriptan—Memory impairment—Temozolomide—malignant glioma	0.00445	0.0186	CcSEcCtD
Rizatriptan—Hyperaesthesia—Temozolomide—malignant glioma	0.00445	0.0186	CcSEcCtD
Rizatriptan—HTR1B—brainstem—malignant glioma	0.00439	0.0126	CbGeAlD
Rizatriptan—HTR1F—brain—malignant glioma	0.00429	0.0123	CbGeAlD
Rizatriptan—HTR1D—brainstem—malignant glioma	0.00425	0.0122	CbGeAlD
Rizatriptan—Disturbance in attention—Temozolomide—malignant glioma	0.00403	0.0168	CcSEcCtD
Rizatriptan—HTR1B—telencephalon—malignant glioma	0.0039	0.0112	CbGeAlD
Rizatriptan—HTR1D—telencephalon—malignant glioma	0.00377	0.0108	CbGeAlD
Rizatriptan—Gait disturbance—Carmustine—malignant glioma	0.0037	0.0155	CcSEcCtD
Rizatriptan—Coordination abnormal—Carmustine—malignant glioma	0.00368	0.0154	CcSEcCtD
Rizatriptan—Hearing impaired—Temozolomide—malignant glioma	0.00367	0.0153	CcSEcCtD
Rizatriptan—Neck pain—Carmustine—malignant glioma	0.00366	0.0153	CcSEcCtD
Rizatriptan—Gait disturbance—Temozolomide—malignant glioma	0.00358	0.015	CcSEcCtD
Rizatriptan—Coordination abnormal—Temozolomide—malignant glioma	0.00355	0.0149	CcSEcCtD
Rizatriptan—HTR1A—brainstem—malignant glioma	0.00354	0.0102	CbGeAlD
Rizatriptan—Musculoskeletal pain—Temozolomide—malignant glioma	0.00353	0.0148	CcSEcCtD
Rizatriptan—MAOA—embryo—malignant glioma	0.00353	0.0101	CbGeAlD
Rizatriptan—MAOA—brainstem—malignant glioma	0.00324	0.00928	CbGeAlD
Rizatriptan—Dry eye—Temozolomide—malignant glioma	0.00322	0.0135	CcSEcCtD
Rizatriptan—HTR1A—telencephalon—malignant glioma	0.00314	0.00901	CbGeAlD
Rizatriptan—MAOA—retina—malignant glioma	0.00312	0.00895	CbGeAlD
Rizatriptan—Swelling—Carmustine—malignant glioma	0.00297	0.0124	CcSEcCtD
Rizatriptan—Ear pain—Temozolomide—malignant glioma	0.00297	0.0124	CcSEcCtD
Rizatriptan—Eye pain—Carmustine—malignant glioma	0.0029	0.0121	CcSEcCtD
Rizatriptan—MAOA—telencephalon—malignant glioma	0.00287	0.00823	CbGeAlD
Rizatriptan—Deafness—Temozolomide—malignant glioma	0.00283	0.0118	CcSEcCtD
Rizatriptan—Eye pain—Temozolomide—malignant glioma	0.00281	0.0117	CcSEcCtD
Rizatriptan—HTR1B—midbrain—malignant glioma	0.0028	0.00802	CbGeAlD
Rizatriptan—HTR1B—spinal cord—malignant glioma	0.00273	0.00783	CbGeAlD
Rizatriptan—HTR1D—midbrain—malignant glioma	0.00271	0.00777	CbGeAlD
Rizatriptan—Hot flush—Temozolomide—malignant glioma	0.00271	0.0113	CcSEcCtD
Rizatriptan—Menopausal symptoms—Temozolomide—malignant glioma	0.00269	0.0112	CcSEcCtD
Rizatriptan—Thirst—Temozolomide—malignant glioma	0.00266	0.0111	CcSEcCtD
Rizatriptan—Face oedema—Carmustine—malignant glioma	0.00253	0.0106	CcSEcCtD
Rizatriptan—Ataxia—Carmustine—malignant glioma	0.00247	0.0103	CcSEcCtD
Rizatriptan—Face oedema—Temozolomide—malignant glioma	0.00245	0.0102	CcSEcCtD
Rizatriptan—Ataxia—Temozolomide—malignant glioma	0.00238	0.00996	CcSEcCtD
Rizatriptan—Dehydration—Temozolomide—malignant glioma	0.00236	0.00985	CcSEcCtD
Rizatriptan—Muscular weakness—Carmustine—malignant glioma	0.00231	0.00967	CcSEcCtD
Rizatriptan—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00228	0.00954	CcSEcCtD
Rizatriptan—Dysphagia—Carmustine—malignant glioma	0.00227	0.00947	CcSEcCtD
Rizatriptan—HTR1A—midbrain—malignant glioma	0.00226	0.00647	CbGeAlD
Rizatriptan—MAOA—medulla oblongata—malignant glioma	0.00226	0.00647	CbGeAlD
Rizatriptan—Muscular weakness—Temozolomide—malignant glioma	0.00223	0.00934	CcSEcCtD
Rizatriptan—HTR1B—central nervous system—malignant glioma	0.00221	0.00635	CbGeAlD
Rizatriptan—Abdominal distension—Temozolomide—malignant glioma	0.0022	0.00922	CcSEcCtD
Rizatriptan—HTR1A—spinal cord—malignant glioma	0.0022	0.00631	CbGeAlD
Rizatriptan—Dysphagia—Temozolomide—malignant glioma	0.00219	0.00916	CcSEcCtD
Rizatriptan—HTR1D—central nervous system—malignant glioma	0.00214	0.00615	CbGeAlD
Rizatriptan—MAOA—midbrain—malignant glioma	0.00206	0.00591	CbGeAlD
Rizatriptan—Dysuria—Temozolomide—malignant glioma	0.00205	0.00856	CcSEcCtD
Rizatriptan—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00204	0.00851	CcSEcCtD
Rizatriptan—Pollakiuria—Temozolomide—malignant glioma	0.00202	0.00846	CcSEcCtD
Rizatriptan—MAOA—spinal cord—malignant glioma	0.00201	0.00577	CbGeAlD
Rizatriptan—Photosensitivity reaction—Temozolomide—malignant glioma	0.002	0.00836	CcSEcCtD
Rizatriptan—Hallucination—Carmustine—malignant glioma	0.0018	0.00755	CcSEcCtD
Rizatriptan—Hypoaesthesia—Carmustine—malignant glioma	0.0018	0.00755	CcSEcCtD
Rizatriptan—HTR1A—central nervous system—malignant glioma	0.00179	0.00512	CbGeAlD
Rizatriptan—HTR1B—brain—malignant glioma	0.00176	0.00504	CbGeAlD
Rizatriptan—HTR1A—cerebellum—malignant glioma	0.00175	0.00501	CbGeAlD
Rizatriptan—Hypoaesthesia—Temozolomide—malignant glioma	0.00174	0.00729	CcSEcCtD
Rizatriptan—Hallucination—Temozolomide—malignant glioma	0.00174	0.00729	CcSEcCtD
Rizatriptan—Pharyngitis—Temozolomide—malignant glioma	0.00174	0.00727	CcSEcCtD
Rizatriptan—HTR1D—brain—malignant glioma	0.0017	0.00488	CbGeAlD
Rizatriptan—Flushing—Carmustine—malignant glioma	0.00168	0.00704	CcSEcCtD
Rizatriptan—Tinnitus—Temozolomide—malignant glioma	0.00163	0.00683	CcSEcCtD
Rizatriptan—MAOA—central nervous system—malignant glioma	0.00163	0.00468	CbGeAlD
Rizatriptan—Flushing—Temozolomide—malignant glioma	0.00163	0.0068	CcSEcCtD
Rizatriptan—Arrhythmia—Carmustine—malignant glioma	0.00162	0.00677	CcSEcCtD
Rizatriptan—MAOA—cerebellum—malignant glioma	0.0016	0.00457	CbGeAlD
Rizatriptan—Angiopathy—Temozolomide—malignant glioma	0.00159	0.00665	CcSEcCtD
Rizatriptan—Mental disorder—Carmustine—malignant glioma	0.00159	0.00664	CcSEcCtD
Rizatriptan—Erythema—Carmustine—malignant glioma	0.00158	0.0066	CcSEcCtD
Rizatriptan—Chills—Temozolomide—malignant glioma	0.00157	0.00658	CcSEcCtD
Rizatriptan—Mental disorder—Temozolomide—malignant glioma	0.00154	0.00642	CcSEcCtD
Rizatriptan—Erythema—Temozolomide—malignant glioma	0.00153	0.00638	CcSEcCtD
Rizatriptan—Dysgeusia—Temozolomide—malignant glioma	0.00149	0.00625	CcSEcCtD
Rizatriptan—Vision blurred—Carmustine—malignant glioma	0.00149	0.00622	CcSEcCtD
Rizatriptan—Tremor—Carmustine—malignant glioma	0.00148	0.00619	CcSEcCtD
Rizatriptan—Agitation—Carmustine—malignant glioma	0.00145	0.00607	CcSEcCtD
Rizatriptan—Vision blurred—Temozolomide—malignant glioma	0.00144	0.00601	CcSEcCtD
Rizatriptan—Tremor—Temozolomide—malignant glioma	0.00143	0.00598	CcSEcCtD
Rizatriptan—HTR1A—brain—malignant glioma	0.00142	0.00407	CbGeAlD
Rizatriptan—Agitation—Temozolomide—malignant glioma	0.0014	0.00586	CcSEcCtD
Rizatriptan—Angioedema—Temozolomide—malignant glioma	0.00139	0.00583	CcSEcCtD
Rizatriptan—Vertigo—Temozolomide—malignant glioma	0.00137	0.00573	CcSEcCtD
Rizatriptan—Convulsion—Carmustine—malignant glioma	0.00137	0.00572	CcSEcCtD
Rizatriptan—Hypertension—Carmustine—malignant glioma	0.00136	0.0057	CcSEcCtD
Rizatriptan—Palpitations—Temozolomide—malignant glioma	0.00135	0.00564	CcSEcCtD
Rizatriptan—Chest pain—Carmustine—malignant glioma	0.00134	0.00562	CcSEcCtD
Rizatriptan—Myalgia—Carmustine—malignant glioma	0.00134	0.00562	CcSEcCtD
Rizatriptan—Anxiety—Carmustine—malignant glioma	0.00134	0.0056	CcSEcCtD
Rizatriptan—Cough—Temozolomide—malignant glioma	0.00133	0.00557	CcSEcCtD
Rizatriptan—Convulsion—Temozolomide—malignant glioma	0.00132	0.00553	CcSEcCtD
Rizatriptan—Hypertension—Temozolomide—malignant glioma	0.00132	0.00551	CcSEcCtD
Rizatriptan—Confusional state—Carmustine—malignant glioma	0.0013	0.00543	CcSEcCtD
Rizatriptan—Arthralgia—Temozolomide—malignant glioma	0.0013	0.00543	CcSEcCtD
Rizatriptan—Myalgia—Temozolomide—malignant glioma	0.0013	0.00543	CcSEcCtD
Rizatriptan—MAOA—brain—malignant glioma	0.0013	0.00372	CbGeAlD
Rizatriptan—Anxiety—Temozolomide—malignant glioma	0.00129	0.00541	CcSEcCtD
Rizatriptan—Oedema—Carmustine—malignant glioma	0.00129	0.00539	CcSEcCtD
Rizatriptan—Discomfort—Temozolomide—malignant glioma	0.00128	0.00537	CcSEcCtD
Rizatriptan—Dry mouth—Temozolomide—malignant glioma	0.00127	0.00531	CcSEcCtD
Rizatriptan—Tachycardia—Carmustine—malignant glioma	0.00126	0.00526	CcSEcCtD
Rizatriptan—Confusional state—Temozolomide—malignant glioma	0.00126	0.00525	CcSEcCtD
Rizatriptan—Oedema—Temozolomide—malignant glioma	0.00125	0.00521	CcSEcCtD
Rizatriptan—Anaphylactic shock—Temozolomide—malignant glioma	0.00125	0.00521	CcSEcCtD
Rizatriptan—Anorexia—Carmustine—malignant glioma	0.00123	0.00514	CcSEcCtD
Rizatriptan—Nervous system disorder—Temozolomide—malignant glioma	0.00122	0.00511	CcSEcCtD
Rizatriptan—Hyperhidrosis—Temozolomide—malignant glioma	0.0012	0.00503	CcSEcCtD
Rizatriptan—Anorexia—Temozolomide—malignant glioma	0.00119	0.00496	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00117	0.00491	CcSEcCtD
Rizatriptan—Insomnia—Carmustine—malignant glioma	0.00117	0.00487	CcSEcCtD
Rizatriptan—Paraesthesia—Carmustine—malignant glioma	0.00116	0.00484	CcSEcCtD
Rizatriptan—Dyspnoea—Carmustine—malignant glioma	0.00115	0.0048	CcSEcCtD
Rizatriptan—Somnolence—Carmustine—malignant glioma	0.00115	0.00479	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00113	0.00474	CcSEcCtD
Rizatriptan—Insomnia—Temozolomide—malignant glioma	0.00113	0.00471	CcSEcCtD
Rizatriptan—Decreased appetite—Carmustine—malignant glioma	0.00112	0.00468	CcSEcCtD
Rizatriptan—Paraesthesia—Temozolomide—malignant glioma	0.00112	0.00468	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Carmustine—malignant glioma	0.00111	0.00465	CcSEcCtD
Rizatriptan—Dyspnoea—Temozolomide—malignant glioma	0.00111	0.00464	CcSEcCtD
Rizatriptan—Somnolence—Temozolomide—malignant glioma	0.00111	0.00463	CcSEcCtD
Rizatriptan—Pain—Carmustine—malignant glioma	0.0011	0.00461	CcSEcCtD
Rizatriptan—Constipation—Carmustine—malignant glioma	0.0011	0.00461	CcSEcCtD
Rizatriptan—Dyspepsia—Temozolomide—malignant glioma	0.0011	0.00458	CcSEcCtD
Rizatriptan—Decreased appetite—Temozolomide—malignant glioma	0.00108	0.00453	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00108	0.0045	CcSEcCtD
Rizatriptan—Fatigue—Temozolomide—malignant glioma	0.00107	0.00449	CcSEcCtD
Rizatriptan—Constipation—Temozolomide—malignant glioma	0.00107	0.00445	CcSEcCtD
Rizatriptan—Pain—Temozolomide—malignant glioma	0.00107	0.00445	CcSEcCtD
Rizatriptan—Feeling abnormal—Carmustine—malignant glioma	0.00106	0.00444	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Carmustine—malignant glioma	0.00105	0.00441	CcSEcCtD
Rizatriptan—Feeling abnormal—Temozolomide—malignant glioma	0.00103	0.00429	CcSEcCtD
Rizatriptan—Body temperature increased—Carmustine—malignant glioma	0.00102	0.00426	CcSEcCtD
Rizatriptan—Abdominal pain—Carmustine—malignant glioma	0.00102	0.00426	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Temozolomide—malignant glioma	0.00102	0.00426	CcSEcCtD
Rizatriptan—Urticaria—Temozolomide—malignant glioma	0.000989	0.00414	CcSEcCtD
Rizatriptan—Abdominal pain—Temozolomide—malignant glioma	0.000985	0.00412	CcSEcCtD
Rizatriptan—Body temperature increased—Temozolomide—malignant glioma	0.000985	0.00412	CcSEcCtD
Rizatriptan—Hypersensitivity—Carmustine—malignant glioma	0.00095	0.00397	CcSEcCtD
Rizatriptan—Asthenia—Carmustine—malignant glioma	0.000925	0.00387	CcSEcCtD
Rizatriptan—Hypersensitivity—Temozolomide—malignant glioma	0.000918	0.00384	CcSEcCtD
Rizatriptan—Asthenia—Temozolomide—malignant glioma	0.000894	0.00374	CcSEcCtD
Rizatriptan—Diarrhoea—Carmustine—malignant glioma	0.000882	0.00369	CcSEcCtD
Rizatriptan—Pruritus—Temozolomide—malignant glioma	0.000881	0.00368	CcSEcCtD
Rizatriptan—Dizziness—Carmustine—malignant glioma	0.000852	0.00356	CcSEcCtD
Rizatriptan—Diarrhoea—Temozolomide—malignant glioma	0.000852	0.00356	CcSEcCtD
Rizatriptan—Dizziness—Temozolomide—malignant glioma	0.000824	0.00344	CcSEcCtD
Rizatriptan—Vomiting—Carmustine—malignant glioma	0.000819	0.00343	CcSEcCtD
Rizatriptan—Rash—Carmustine—malignant glioma	0.000813	0.0034	CcSEcCtD
Rizatriptan—Dermatitis—Carmustine—malignant glioma	0.000812	0.00339	CcSEcCtD
Rizatriptan—Headache—Carmustine—malignant glioma	0.000807	0.00338	CcSEcCtD
Rizatriptan—Vomiting—Temozolomide—malignant glioma	0.000792	0.00331	CcSEcCtD
Rizatriptan—Rash—Temozolomide—malignant glioma	0.000785	0.00328	CcSEcCtD
Rizatriptan—Dermatitis—Temozolomide—malignant glioma	0.000785	0.00328	CcSEcCtD
Rizatriptan—Headache—Temozolomide—malignant glioma	0.00078	0.00326	CcSEcCtD
Rizatriptan—Nausea—Carmustine—malignant glioma	0.000766	0.0032	CcSEcCtD
Rizatriptan—Nausea—Temozolomide—malignant glioma	0.00074	0.00309	CcSEcCtD
Rizatriptan—HTR1F—Signaling by GPCR—EGFR—malignant glioma	4.69e-05	0.000429	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CDKN2B—malignant glioma	4.68e-05	0.000428	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—NCOR1—malignant glioma	4.66e-05	0.000426	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—YWHAE—malignant glioma	4.65e-05	0.000425	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NTRK2—malignant glioma	4.65e-05	0.000425	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FLT1—malignant glioma	4.63e-05	0.000423	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MMP3—malignant glioma	4.62e-05	0.000422	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—PIK3CB—malignant glioma	4.61e-05	0.000421	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—DUSP6—malignant glioma	4.61e-05	0.000421	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PIK3CG—malignant glioma	4.58e-05	0.000419	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CDKN2B—malignant glioma	4.58e-05	0.000419	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—JAG1—malignant glioma	4.55e-05	0.000415	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PTK2—malignant glioma	4.54e-05	0.000415	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PIK3CD—malignant glioma	4.53e-05	0.000414	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOTCH3—malignant glioma	4.53e-05	0.000414	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—CXCL8—malignant glioma	4.52e-05	0.000413	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—PIK3CA—malignant glioma	4.49e-05	0.00041	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HES1—malignant glioma	4.46e-05	0.000408	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FBXW7—malignant glioma	4.45e-05	0.000407	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PTK2—malignant glioma	4.45e-05	0.000407	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NCOR1—malignant glioma	4.44e-05	0.000406	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—KRAS—malignant glioma	4.44e-05	0.000405	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CXCL8—malignant glioma	4.43e-05	0.000405	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—RAF1—malignant glioma	4.38e-05	0.0004	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HES1—malignant glioma	4.37e-05	0.000399	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—BDKRB2—malignant glioma	4.37e-05	0.000399	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—F2—malignant glioma	4.35e-05	0.000397	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NCOR1—malignant glioma	4.35e-05	0.000397	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—FGF2—malignant glioma	4.34e-05	0.000396	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—IL2—malignant glioma	4.32e-05	0.000395	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—RAF1—malignant glioma	4.29e-05	0.000392	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—PIK3CB—malignant glioma	4.27e-05	0.000391	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PDGFRA—malignant glioma	4.25e-05	0.000388	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—IL2—malignant glioma	4.23e-05	0.000387	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—AKT2—malignant glioma	4.19e-05	0.000383	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PIK3CB—malignant glioma	4.19e-05	0.000382	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PDGFRA—malignant glioma	4.16e-05	0.00038	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CG—malignant glioma	4.16e-05	0.00038	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SPP1—malignant glioma	4.13e-05	0.000377	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CXCL8—malignant glioma	4.11e-05	0.000375	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—IDH2—malignant glioma	4.09e-05	0.000374	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PTPN11—malignant glioma	4.09e-05	0.000374	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—PIK3CA—malignant glioma	4.07e-05	0.000372	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOTCH2—malignant glioma	4.06e-05	0.000371	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MDM2—malignant glioma	4.06e-05	0.000371	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—RAF1—malignant glioma	4.04e-05	0.00037	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SPP1—malignant glioma	4.04e-05	0.000369	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PIK3CD—malignant glioma	4.03e-05	0.000368	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CXCL8—malignant glioma	4.02e-05	0.000368	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ERBB2—malignant glioma	4e-05	0.000366	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KNG1—malignant glioma	3.97e-05	0.000363	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PIK3CB—malignant glioma	3.95e-05	0.000361	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL2—malignant glioma	3.93e-05	0.000359	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TERT—malignant glioma	3.91e-05	0.000357	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.86e-05	0.000352	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP2B6—malignant glioma	3.85e-05	0.000351	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL2—malignant glioma	3.84e-05	0.000351	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TERT—malignant glioma	3.83e-05	0.00035	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PDGFB—malignant glioma	3.82e-05	0.000349	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AKT2—malignant glioma	3.81e-05	0.000348	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FGFR1—malignant glioma	3.8e-05	0.000347	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CAV1—malignant glioma	3.8e-05	0.000347	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CXCL8—malignant glioma	3.79e-05	0.000347	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NTRK1—malignant glioma	3.79e-05	0.000346	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HIF1A—malignant glioma	3.74e-05	0.000342	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PDGFB—malignant glioma	3.74e-05	0.000342	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FGFR1—malignant glioma	3.72e-05	0.00034	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—AKT1—malignant glioma	3.67e-05	0.000335	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HIF1A—malignant glioma	3.66e-05	0.000335	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CD—malignant glioma	3.66e-05	0.000334	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CASP3—malignant glioma	3.63e-05	0.000332	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL2—malignant glioma	3.63e-05	0.000331	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CAV1—malignant glioma	3.62e-05	0.000331	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KDR—malignant glioma	3.58e-05	0.000327	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CAV1—malignant glioma	3.54e-05	0.000324	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MMP3—malignant glioma	3.52e-05	0.000322	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—IDH1—malignant glioma	3.52e-05	0.000321	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PIK3CB—malignant glioma	3.51e-05	0.000321	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KDR—malignant glioma	3.5e-05	0.00032	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CDKN2B—malignant glioma	3.49e-05	0.000319	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CG—malignant glioma	3.46e-05	0.000316	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—F2—malignant glioma	3.44e-05	0.000315	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FN1—malignant glioma	3.44e-05	0.000315	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MMP9—malignant glioma	3.43e-05	0.000314	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PTEN—malignant glioma	3.41e-05	0.000312	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SPHK1—malignant glioma	3.4e-05	0.000311	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—BAD—malignant glioma	3.4e-05	0.000311	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTK2—malignant glioma	3.39e-05	0.00031	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CXCL8—malignant glioma	3.37e-05	0.000308	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FN1—malignant glioma	3.37e-05	0.000308	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—F2—malignant glioma	3.37e-05	0.000308	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NOTCH1—malignant glioma	3.37e-05	0.000308	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PPARG—malignant glioma	3.34e-05	0.000305	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP2C18—malignant glioma	3.33e-05	0.000305	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—BAD—malignant glioma	3.33e-05	0.000304	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HES1—malignant glioma	3.33e-05	0.000304	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—AKT1—malignant glioma	3.33e-05	0.000304	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NCOR1—malignant glioma	3.31e-05	0.000302	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CD80—malignant glioma	3.3e-05	0.000302	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NOTCH1—malignant glioma	3.3e-05	0.000302	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CG—malignant glioma	3.3e-05	0.000301	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APC—malignant glioma	3.3e-05	0.000301	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—RAF1—malignant glioma	3.27e-05	0.000298	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EGF—malignant glioma	3.26e-05	0.000298	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PTPN11—malignant glioma	3.24e-05	0.000296	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CD80—malignant glioma	3.23e-05	0.000295	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CG—malignant glioma	3.23e-05	0.000295	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APC—malignant glioma	3.23e-05	0.000295	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—IL2—malignant glioma	3.22e-05	0.000295	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EGF—malignant glioma	3.19e-05	0.000291	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CB—malignant glioma	3.19e-05	0.000291	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PDGFRA—malignant glioma	3.17e-05	0.00029	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PTPN11—malignant glioma	3.17e-05	0.00029	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.14e-05	0.000287	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—BRAF—malignant glioma	3.1e-05	0.000283	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—VEGFA—malignant glioma	3.08e-05	0.000282	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SPP1—malignant glioma	3.08e-05	0.000281	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CXCL8—malignant glioma	3.06e-05	0.00028	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—STAT3—malignant glioma	3.05e-05	0.000279	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CD—malignant glioma	3.04e-05	0.000278	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—BRAF—malignant glioma	3.03e-05	0.000277	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AKT2—malignant glioma	3.02e-05	0.000276	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—EGFR—malignant glioma	3e-05	0.000274	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AKT2—malignant glioma	2.95e-05	0.00027	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—EGFR—malignant glioma	2.94e-05	0.000269	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL2—malignant glioma	2.93e-05	0.000268	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TERT—malignant glioma	2.92e-05	0.000267	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CD—malignant glioma	2.9e-05	0.000265	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—PIK3CA—malignant glioma	2.87e-05	0.000262	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.86e-05	0.000262	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PDGFB—malignant glioma	2.85e-05	0.00026	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CD—malignant glioma	2.84e-05	0.000259	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—KRAS—malignant glioma	2.84e-05	0.000259	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MYC—malignant glioma	2.84e-05	0.000259	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGFR1—malignant glioma	2.83e-05	0.000259	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—PIK3CA—malignant glioma	2.81e-05	0.000257	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HIF1A—malignant glioma	2.79e-05	0.000255	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—KRAS—malignant glioma	2.78e-05	0.000254	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—FGF2—malignant glioma	2.77e-05	0.000253	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—EGFR—malignant glioma	2.77e-05	0.000253	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.76e-05	0.000253	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FGF2—malignant glioma	2.72e-05	0.000248	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CAV1—malignant glioma	2.7e-05	0.000247	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTT1—malignant glioma	2.7e-05	0.000246	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KDR—malignant glioma	2.67e-05	0.000244	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CB—malignant glioma	2.65e-05	0.000242	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTGS2—malignant glioma	2.63e-05	0.00024	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—KRAS—malignant glioma	2.62e-05	0.000239	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—PIK3CA—malignant glioma	2.61e-05	0.000238	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MDM2—malignant glioma	2.6e-05	0.000237	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—RAF1—malignant glioma	2.59e-05	0.000236	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—F2—malignant glioma	2.57e-05	0.000235	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FN1—malignant glioma	2.57e-05	0.000235	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ERBB2—malignant glioma	2.56e-05	0.000234	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PIK3CA—malignant glioma	2.55e-05	0.000233	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MDM2—malignant glioma	2.54e-05	0.000232	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—BAD—malignant glioma	2.54e-05	0.000232	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—RAF1—malignant glioma	2.53e-05	0.000231	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS1—malignant glioma	2.53e-05	0.000231	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CB—malignant glioma	2.53e-05	0.000231	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.52e-05	0.00023	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOTCH1—malignant glioma	2.51e-05	0.00023	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ERBB2—malignant glioma	2.51e-05	0.000229	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CB—malignant glioma	2.47e-05	0.000226	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CD80—malignant glioma	2.46e-05	0.000225	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CG—malignant glioma	2.46e-05	0.000225	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APC—malignant glioma	2.46e-05	0.000225	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EGF—malignant glioma	2.43e-05	0.000222	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CXCL8—malignant glioma	2.43e-05	0.000222	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTPN11—malignant glioma	2.41e-05	0.000221	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PIK3CA—malignant glioma	2.41e-05	0.00022	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CXCL8—malignant glioma	2.38e-05	0.000217	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—BCHE—malignant glioma	2.35e-05	0.000215	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—AKT1—malignant glioma	2.34e-05	0.000214	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TP53—malignant glioma	2.33e-05	0.000213	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CASP3—malignant glioma	2.32e-05	0.000212	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC5A5—malignant glioma	2.32e-05	0.000212	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL2—malignant glioma	2.32e-05	0.000212	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—BRAF—malignant glioma	2.31e-05	0.000211	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—AKT1—malignant glioma	2.3e-05	0.00021	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTEN—malignant glioma	2.29e-05	0.000209	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CASP3—malignant glioma	2.27e-05	0.000208	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL2—malignant glioma	2.27e-05	0.000207	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKT2—malignant glioma	2.25e-05	0.000206	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—EGFR—malignant glioma	2.24e-05	0.000205	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MMP9—malignant glioma	2.19e-05	0.000201	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.19e-05	0.000201	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PTEN—malignant glioma	2.18e-05	0.000199	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.17e-05	0.000199	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CD—malignant glioma	2.16e-05	0.000197	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MMP9—malignant glioma	2.15e-05	0.000196	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PIK3CA—malignant glioma	2.14e-05	0.000196	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PTEN—malignant glioma	2.14e-05	0.000195	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—AKT1—malignant glioma	2.13e-05	0.000195	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—KRAS—malignant glioma	2.12e-05	0.000193	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—AKT1—malignant glioma	2.08e-05	0.00019	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGF2—malignant glioma	2.07e-05	0.000189	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—VEGFA—malignant glioma	1.97e-05	0.00018	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—AKT1—malignant glioma	1.97e-05	0.00018	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—STAT3—malignant glioma	1.95e-05	0.000178	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CA—malignant glioma	1.94e-05	0.000178	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MDM2—malignant glioma	1.94e-05	0.000177	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—VEGFA—malignant glioma	1.93e-05	0.000176	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RAF1—malignant glioma	1.93e-05	0.000176	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—STAT3—malignant glioma	1.91e-05	0.000175	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ERBB2—malignant glioma	1.91e-05	0.000174	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.9e-05	0.000173	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CB—malignant glioma	1.88e-05	0.000172	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTP1—malignant glioma	1.87e-05	0.000171	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CAT—malignant glioma	1.82e-05	0.000166	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MYC—malignant glioma	1.81e-05	0.000166	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCL8—malignant glioma	1.81e-05	0.000165	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MYC—malignant glioma	1.78e-05	0.000162	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EGFR—malignant glioma	1.77e-05	0.000162	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	1.75e-05	0.00016	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EGFR—malignant glioma	1.74e-05	0.000159	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CASP3—malignant glioma	1.73e-05	0.000158	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL2—malignant glioma	1.73e-05	0.000158	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NCOR1—malignant glioma	1.72e-05	0.000157	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KRAS—malignant glioma	1.68e-05	0.000153	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KRAS—malignant glioma	1.64e-05	0.00015	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MMP9—malignant glioma	1.64e-05	0.00015	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTEN—malignant glioma	1.63e-05	0.000149	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CA—malignant glioma	1.62e-05	0.000148	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AKT1—malignant glioma	1.59e-05	0.000145	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CA—malignant glioma	1.54e-05	0.000141	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CA—malignant glioma	1.51e-05	0.000138	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TP53—malignant glioma	1.49e-05	0.000136	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—VEGFA—malignant glioma	1.47e-05	0.000134	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TP53—malignant glioma	1.46e-05	0.000133	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—STAT3—malignant glioma	1.46e-05	0.000133	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CAV1—malignant glioma	1.4e-05	0.000128	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MYC—malignant glioma	1.35e-05	0.000124	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.34e-05	0.000122	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EGFR—malignant glioma	1.32e-05	0.000121	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—AKT1—malignant glioma	1.32e-05	0.000121	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.28e-05	0.000117	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AKT1—malignant glioma	1.26e-05	0.000115	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KRAS—malignant glioma	1.25e-05	0.000114	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AKT1—malignant glioma	1.23e-05	0.000113	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPARG—malignant glioma	1.23e-05	0.000112	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	1.15e-05	0.000105	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.12e-05	0.000102	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TP53—malignant glioma	1.11e-05	0.000101	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CB—malignant glioma	9.77e-06	8.93e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS2—malignant glioma	9.68e-06	8.85e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKT1—malignant glioma	9.38e-06	8.57e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTEN—malignant glioma	8.44e-06	7.72e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CA—malignant glioma	5.96e-06	5.44e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AKT1—malignant glioma	4.87e-06	4.45e-05	CbGpPWpGaD
